Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen Mayo currently holds 18,640 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Mayo has been a net seller of SRPT stock. They have purchased $0 and sold $645.9K worth of shares.
Stephen Mayo's most recent insider trade was on Jun 4, 2026, when they sold 16,875 shares at $0.00 per share.
Stephen Mayo serves as Executive at Sarepta Therapeutics, Inc. (SRPT). They have executed 13 insider transactions totaling $645.9K over their tenure at the company.
Stephen Mayo holds the position of Executive at Sarepta Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Stephen Mayo has shown a selling trading pattern, with $0 in total purchases and $645.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stephen Mayo was on Mar 5, 2024, when they sold $385.5K worth of SRPT shares. This transaction involved 3,135 shares at $122.96 per share.
Stephen Mayo currently owns 18,640 shares of Sarepta Therapeutics, Inc. (SRPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen Mayo's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen Mayo has 13 Form 4 filings on record as an insider at Sarepta Therapeutics, Inc..
Set alerts for Stephen Mayo and 40,000+ other insiders.